Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Craig Hall

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
AJR. American Journal of Roentgenology|April 24, 2007
Microwave ablation of renal parenchymal tumors before nephrectomy: phase I studyPeter E Clark, Ralph D Woodruff, Ronald J Zagoria, et al.
Urologic Oncology|May 8, 2007
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?Joseph J Phillips, M Craig Hall, W Robert Lee, et al.
Current Urology Reports|January 22, 2004
Radiofrequency ablation of renal tumorsBrian R Matlaga, Ronald J Zagoria, Peter E Clark, et al.
Endocrinology|October 9, 2004
A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancerWendy W Barclay, Ralph D Woodruff, M Craig Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancerGary G Schwartz, M Craig Hall, Diana Stindt, et al.
AJR. American Journal of Roentgenology|June 24, 2003
Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomyCharles A McLaughlin, Michael Y Chen, Frank M Torti, et al.
The Journal of Urology|November 21, 2002
Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zoneBrian R Matlaga, Ronald J Zagoria, Ralph D Woodruff, et al.
Urologic Oncology|September 8, 2005
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern eraPeter E Clark, Joseph A Veys, Matthew R Eskridge, et al.
Cancer Research|February 12, 2004
Deficient nucleotide excision repair capacity enhances human prostate cancer riskJennifer J Hu, M Craig Hall, Lawrence Grossman, et al.
AJR. American Journal of Roentgenology|May 23, 2007
CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablationMarta E Heilbrun, Ronald J Zagoria, A Julian Garvin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
AJR. American Journal of Roentgenology|April 24, 2007
Microwave ablation of renal parenchymal tumors before nephrectomy: phase I studyPeter E Clark, Ralph D Woodruff, Ronald J Zagoria, et al.
Urologic Oncology|May 8, 2007
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?Joseph J Phillips, M Craig Hall, W Robert Lee, et al.
Current Urology Reports|January 22, 2004
Radiofrequency ablation of renal tumorsBrian R Matlaga, Ronald J Zagoria, Peter E Clark, et al.
Endocrinology|October 9, 2004
A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancerWendy W Barclay, Ralph D Woodruff, M Craig Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancerGary G Schwartz, M Craig Hall, Diana Stindt, et al.
AJR. American Journal of Roentgenology|June 24, 2003
Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomyCharles A McLaughlin, Michael Y Chen, Frank M Torti, et al.
The Journal of Urology|November 21, 2002
Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zoneBrian R Matlaga, Ronald J Zagoria, Ralph D Woodruff, et al.
Urologic Oncology|September 8, 2005
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern eraPeter E Clark, Joseph A Veys, Matthew R Eskridge, et al.
Cancer Research|February 12, 2004
Deficient nucleotide excision repair capacity enhances human prostate cancer riskJennifer J Hu, M Craig Hall, Lawrence Grossman, et al.
AJR. American Journal of Roentgenology|May 23, 2007
CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablationMarta E Heilbrun, Ronald J Zagoria, A Julian Garvin, et al.
Pageof 4